REFERENCES
- Pisani P: Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83:18–29. [PUBMED], [INFOTRIEVE]
- Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1999. CA Cancer J Clin. 1999;49:8–31. [PUBMED], [INFOTRIEVE], [CSA]
- Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ: Cancer statistics. CA Cancer J Clin. 2004;54:8–29. [PUBMED], [INFOTRIEVE]
- Satcher D, Thompson TG, Koplan JP: Women and smoking: a report of the Surgeon General. Nicotine Tob Res. 2002;4:7–20. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Thun MJ, Henley SJ, Calle EE: Tobacco use and cancer: an epidemiologic perspective for geneticists. Oncogene. 2002;21:7307–7325. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kiyohara C, Otsu A, Shirakawa T, Fukuda S, Hopkin JM: Genetic polymorphisms and lung cancer susceptibility: a review. Lung Cancer. 2002;37:241–256. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Schwartz AG: Genetic predisposition to lung cancer. Chest. 2004;125:86S–89S. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 1999;286:531–537. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Petersen S, Heckert C, Rudolf J, Schluns K, Tchernitsa OI, Schafer R, Dietel M, Petersen I: Gene expression profiling of advanced lung cancer. Int J Cancer. 2000;86:512–517. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Yanagisawa K, Shyr Y, Xu BJ, Massion PP, Larsen PH, White BC, Roberts JR, Edgerton M, Gonzales A, Nadaf S, Moore JH, Caprioli RM, Carbone DP: Proteomic patterns of tumor subsets in non-small-cell lung cancer. Lancet. 2003;362:433–439. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Wikman H, Kettunen E, Seppanen JK, Karjalainen A, Hollmen J, Anttila S, Knuutila S: Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene. 2002;21:5804–5813. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, Lizyness ML, Kuick R, Hayasaka S, Taylor JM, Iannettoni MD, Orringer MB, Hanash S: Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med. 2002;8:816–824. [PUBMED], [INFOTRIEVE], [CSA]
- Yao R, Wang Y, Lubet RA, You M: Differentially expressed genes associated with mouse lung tumor progression. Oncogene. 2002;21:5814–5821. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tripodis N, Demant P: Genetic analysis of three-dimensional shape of mouse lung tumors reveals eight lung tumor shape-determining (Ltsd) loci that are associated with tumor heterogeneity and symmetry. Cancer Res. 2003;63:125–131. [PUBMED], [INFOTRIEVE]
- Fijneman RJ, deVries SS, Jansen RC, Demant P: Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse. Nat Genet. 1996;14:465–467. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Manenti G, Gariboldi M, Fiorino A, Zanesi N, Pierotti MA, Dragani TA: Genetic mapping of lung cancer modifier loci specifically affecting tumor initiation and progression. Cancer Res. 1997;57:4164–4166. [PUBMED], [INFOTRIEVE]
- Fijneman RJ, Jansen RC, van der Valk MA, Demant P: High frequency of interactions between lung cancer susceptibility genes in the mouse: mapping of Sluc5 to Sluc14. Cancer Res. 1998;58:4794–4798. [PUBMED], [INFOTRIEVE]
- Festing MF, Lin L, Devereux TR, Gao F, Yang A, Anna CH, White CM, Malkinson AM, You M: At least four loci and gender are associated with susceptibility to the chemical induction of lung adenomas in A/J×BALB/c mice. Genomics. 1998;53:129–136. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tripodis N, Hart AA, Fijneman RJ, Demant P: Complexity of lung cancer modifiers: mapping of thirty genes and twenty-five interactions in half of the mouse genome. J Natl Cancer Inst. 2001;93:1484–1491. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Beer DG, Malkinson AM: Genetic influence on type 2 or Clara cell origin of pulmonary adenomas in urethan-treated mice. J Natl Cancer Inst. 1985;75:963–969. [PUBMED], [INFOTRIEVE]
- Oomen LC, van derValk MA, Demant P: MHC and non-MHC genes in lung tumor susceptibility in the mouse: implications for the study of the different lung tumor types and their cell of origin. Exp Lung Res. 1991;17:283–304. [PUBMED], [INFOTRIEVE], [CSA]
- Thaete LG, Nesbitt MN, Malkinson AM: Lung adenoma structure among inbred strains of mice: the pulmonary adenoma histologic type (Pah) genes. Cancer Lett. 1991;61:15–20. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Tripodis N, Demant P: Genetic linkage of nuclear morphology of mouse lung tumors to the Kras2 locus. Exp Lung Res. 2001;27:185–196. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Stassen AP, Groot PC, Eppig JT, Demant P: Genetic composition of the recombinant congenic strains. Mamm Genome. 1996;7:55–58. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Fijneman RJ, van derValk MA, Demant P: Genetics of quantitative and qualitative aspects of lung tumorigenesis in the mouse: multiple interacting Susceptibility to lung cancer (Sluc) genes with large effects. Exp Lung Res. 1998;24:419–436. [PUBMED], [INFOTRIEVE], [CSA]
- Tripodis N, Demant P: Three-dimensional patters of lung tumor growth: association with tumor heterogeneity. Exp Lung Res. 2001;27:521–531. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Iona S, Klinger FG, Sisti R, Ciccalese R, Nunziata A, De Felici M: A comparative study of cytotoxic effects of N-ethyl-N-nitrosourea, adriamycin, and mono-(2-ethylhexyl)phthalate on mouse primordial germ cells. Cell Biol Toxicol. 2002;18:131–145. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Katayama K, Ueno M, Takai H, Ejiri N, Uetsuka K, Nakayama H, Doi K: Ethylnitrosourea induces apoptosis and growth arrest in the trophoblastic cells of rat placenta. Biol Reprod. 2002;67:431–435. [PUBMED], [INFOTRIEVE], [CSA]
- Driscoll KE, Deyo LC, Howard BW, Poynter J, Carter JM: Characterizing mutagenesis in the hprt gene of rat alveolar epithelial cells. Exp Lung Res. 1995;21:941–956. [PUBMED], [INFOTRIEVE], [CSA]
- Minoo P, King R: Epithelial-mesenchymal interaction in lung development. Annu Rev Physiol. 1994;56:13–45. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Jackson EL, Willis N, Mercer K, Bronson RT, Crowley D, Montoya R, Jacks T, Tuveson DA: Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 2001;15:3243–3248. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rehm S, Devor DE, Henneman JR, Ward JM: Origin of spontaneous and transplacentally induced mouse lung tumors from alveolar type II cells. Exp Lung Res. 1991;17:181–195. [PUBMED], [INFOTRIEVE]
- Rehm S, Ward JM, ten Have-Opbroek AA, Anderson LM, Singh G, Katyal SL, Rice JM: Mouse papillary lung tumors transplacentally induced by N-nitrosoethylurea: evidence for alveolar type II cell origin by comparative light microscopic, ultrastructural, and immunohistochemical studies. Cancer Res. 1988;48:148–160. [PUBMED], [INFOTRIEVE]
- Thaete LG, Malkinson AM: Differential staining of normal and neoplastic mouse lung epithelia by succinate dehydrogenase histochemistry. Cancer Lett. 1991;17:219–227.
- Mason RJ, Kalina M, Nielsen LD, Malkinson AM, Shannon JM: Surfactant protein C expression in urethane-induced murine pulmonary tumors. Am J Pathol. 2000;156:175–182. [PUBMED], [INFOTRIEVE]
- Warburton D, Schwarz M, Tefft D, Flores-Delgado G, Anderson KD, Cardoso WV: The molecular basis of lung morphogenesis. Mech Dev. 2000;92:55–81. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Branstetter DG, Stoner GD, Budd C, Conran PB, Goldblatt PJ: Effect of gestational development of lung tumor size and morphology in the mouse. Cancer Res. 1988;48:379–386. [PUBMED], [INFOTRIEVE]
- Kauffman SL: Susceptibility of fetal lung to transplacental 1-ethyl-1-nitrosourea: its relation to epithelial proliferation. J Natl Cancer Inst. 1976;57:821–825. [PUBMED], [INFOTRIEVE]
- Rice JM. The biological behaviour of transplacentally induced tumors in mice. In: Thomatis L and V. Mohr, eds. Transplacental Carcinogenesis. IARC Publication No. 4. Lyon France: International Agency for Cancer Research; 1973:71–83.
- Branstetter DG, Moseley PP: Effect of lung development on the histological pattern of lung tumors induced by ethylnitrosourea in the C3HeB/FeJ mouse. Exp Lung Res. 1991;17:169–179. [PUBMED], [INFOTRIEVE]
- Oomen LC, Van derValk MA, Hart AA, Demant P: Glucocorticoid hormone effect on transplacental carcinogenesis and lung differentiation: influence of histocompatibility-2 complex. J Natl Cancer Inst. 1989;81:512–517. [PUBMED], [INFOTRIEVE]
- Haigis KM, Hoff PD, White A, Shoemaker AR, Halberg RB, Dove WF: Tumor regionality in the mouse intestine reflects the mechanisms of loss of Apc function. Proc Natl Acad Sciences USA. 2004;101:9769–9773. [CSA], [CROSSREF]
- Coussens LM, Werb Z: Inflammation and cancer. Nature. 2002;420:860–867. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Fijneman RJ, Vos M, Berkhof J, Demant P, Kraal G: Genomic analysis of macrophage characteristics as a tool to identify tumor susceptibility genes: mapping of three macrophage-associated risk inflammatory factors, Marif1, Marif2, and Marif3. Cancer Res. 2004;64:3458–3464. [PUBMED], [INFOTRIEVE]
- Lipoldova M, Havelkova H, Badalova J, Demant P: Novel loci controlling lymphocyte proliferative response to cytokines and their clustering with loci controlling autoimmune reactions, macrophage function, and lung tumor susceptibility. Int J Cancer. 2005;114:394–399. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301–314. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Chen Q, Wang WC, Evans SS: Tumor microvasculature as a barrier to anti-tumor immunity. Cancer Immunol Immunother. 2003;52:670–679. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]